Axcelis Technologies, Inc. (ACLS) – What Are Researchers Thinking About This Stock?

Posted by George Bondi on Oct 12th, 2026

Shares of Axcelis Technologies, Inc. (NASDAQ:ACLS – Get Free Report) have been given a consensus recommendation of “Hold” by the five research firms that are presently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and one has issued a buy recommendation on the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $148.67.

ACLS has been the topic of a number of recent research reports. Craig Hallum lowered shares of Axcelis Technologies from a “buy” rating to a “hold” rating and set a $140.00 price target on the stock. in a research report on Friday, August 7th. Bank of America boosted their price objective on shares of Axcelis Technologies from $130.00 to $156.00 and gave the company an “underperform” rating in a report on Tuesday, June 23rd. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Axcelis Technologies in a research report on Friday, August 7th.

Get Our Latest Stock Analysis on ACLS

Hedge Funds Weigh In On Axcelis Technologies

Several hedge funds and other institutional investors have recently made changes to their positions in ACLS. Wellington Management Group LLP acquired a new position in Axcelis Technologies during the second quarter worth about $13,070,000. The Manufacturers Life Insurance Company lifted its holdings in shares of Axcelis Technologies by 3,402.5% in the first quarter. The Manufacturers Life Insurance Company now owns 491,745 shares of the semiconductor company’s stock worth $45,772,000 after acquiring an additional 477,705 shares during the last quarter. Peterson Wealth Services lifted its holdings in shares of Axcelis Technologies by 1,750.8% in the fourth quarter. Peterson Wealth Services now owns 7,403 shares of the semiconductor company’s stock worth $595,000 after acquiring an additional 7,003 shares during the last quarter. Entropy Technologies LP bought a new position in shares of Axcelis Technologies in the first quarter worth about $1,004,000. Finally, Segall Bryant & Hamill LLC boosted its stake in shares of Axcelis Technologies by 96.1% in the 1st quarter. Segall Bryant & Hamill LLC now owns 200,371 shares of the semiconductor company’s stock valued at $18,651,000 after purchasing an additional 98,184 shares in the last quarter. 89.98% of the stock is currently owned by institutional investors and hedge funds.

Axcelis Technologies Stock Performance

Shares of NASDAQ ACLS opened at $134.71 on Monday. The company has a current ratio of 4.90, a quick ratio of 3.21 and a debt-to-equity ratio of 0.04. Axcelis Technologies has a 12 month low of $73.60 and a 12 month high of $193.78. The stock has a 50 day moving average of $125.08 and a 200-day moving average of $136.29. The company has a market capitalization of $4.16 billion, a P/E ratio of 45.20, a P/E/G ratio of 4.12 and a beta of 1.86.

Axcelis Technologies (NASDAQ:ACLS – Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The semiconductor company reported $1.06 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.17. Axcelis Technologies had a net margin of 10.71% and a return on equity of 11.69%. The company had revenue of $215.18 million for the quarter, compared to analyst estimates of $205.03 million. During the same period in the prior year, the firm earned $1.13 earnings per share. The company’s revenue was up 10.6% on a year-over-year basis. Axcelis Technologies has set its Q3 2026 guidance at 1.110-1.110 EPS. As a group, equities research analysts predict that Axcelis Technologies will post 3.39 EPS for the current year.

Axcelis Technologies Company Profile

(Get Free Report)

Axcelis Technologies, Inc (NASDAQ: ACLS) develops and manufactures equipment used in semiconductor fabrication. The company’s primary business is ion implantation, a process that modifies the electrical properties of silicon and other semiconductor materials by introducing controlled amounts of dopants. Its systems are used by chip manufacturers to produce a range of semiconductor devices.

Axcelis offers the Purion family of ion implantation systems, including platforms designed for high-current, medium-current and high-energy applications.